[PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection]

J. Kotzerke; D. Bohmer; T. Schlomm; T. Maurer; A. J. Beer; H. Schmidberger

doi:10.3413/Nukmed-2018030003

[PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection]

J. Kotzerke
D. Bohmer
T. Schlomm
T. Maurer
A. J. Beer
H. Schmidberger

Abstract

The debate refers the known evidence for PSMA-PET/CT in biochemical recurrence of prostate cancer and consider carefully interdisciplinary in which situation which patient needs imaging to choose the adequate therapeutic option. General aspects for the care of cancer patients are taken into consideration.

Bibliografische Daten

Originalsprache	Deutsch
ISSN	0029-5566
DOIs	https://doi.org/10.3413/Nukmed-2018030003
Status	Veröffentlicht - 2018
Extern publiziert	Ja

Anmerkungen des Dekanats

2567-6407 Kotzerke, Jorg Bohmer, Dirk Schlomm, Thorsten Maurer, Thomas Beer, Ambros J Schmidberger, Heinz Journal Article Germany Nuklearmedizin. 2018 Jun;57(3):69-73. doi: 10.3413/Nukmed-2018030003. Epub 2018 Jun 5.